The global Chromatography Instrumentation Market was worth US$ 7.71 Billion in the year 2022 and is expected to reach US$ 12.17 Billion by the year 2032 at a CAGR of 5.2% between 2022 and 2032. Modern HPLC (high-performance liquid chromatography) makes use of high pressure for forcing the mobile phase and analyte via closed column …
Category Archives: Healthcare Trends
Cirrhosis Management Market is anticipated to grow at a CAGR of 3.8% by 2032, reaching US$ 1,059 Million | FMI Report
The global Cirrhosis Management market, which was worth US$ 701.8 million in 2022, is expected to grow at a CAGR of 3.8% between 2022 and 2032, reaching US$ 1,059 million. The market grew at a compound annual rate of 3.5% between 2016 and 2021. The global increase in liver cirrhosis caused by hepatitis infections could …
Point Of Care Blood Testing Devices Market is led by the healthcare and diagnostics industry | Future Market Insights, Inc
The Point Of Care Blood Testing Devices Market is anticipated to reach US$ 49,973.6 million in value by 2032, up from US$ 15,362.4 million in 2022, growing at a CAGR of 11.3% during the projection period. Point of care or POC blood testing devices are easy handheld devices which are used to perform various blood …
Medical Polyetheretherketone Market is expected to climb considerably in the United States during the forecast to 2032 | FMI Study
The global Medical Polyetheretherketone Market is expected to reach a market valuation of US$ 572.54 Million by 2022, accelerating with a moderate CAGR of 7.3% by 2022-2032. The medical polyetheretherketone market size is anticipated to be valued at about US$ 1158.26 Million by 2032 end. Increased adoption of medical polyetheretherketone as a substitute for metals has …
Compression Veterinary Bandages Market is estimated to grow at a CAGR of 3.2%, with a closing value of US$ 160.5 million by 2032
The global Compression Veterinary Bandages Market is anticipated to be worth US$ 113.8 million by the end of 2022. The market is estimated to grow at a 3.2% CAGR from 2022 to 2032, with a closing value of US$ 160.5 million. The industry increased at a 3.6% CAGR between 2016 and 2021. “The rise in …
Filariasis Treatment Market Status and Prospects 2023 to 2033 | By Pfizer, AbbVie, Elsai, Cipla, Novartis AG
Future Market Insights predicts that the global Filariasis Treatment market demand will experience a 10.1% compound annual growth rate (CAGR) between 2023 and 2033, with an estimated value of US$ 28.68 billion by 2033. The growth in the market is expected to be driven by the rising prevalence of filariasis, improved diagnostic capabilities, and increased …
Cancer Biopsy Market is projected to increase at a CAGR of around 18% from 2023 to 2033
The Cancer Biopsy market revenues were estimated at US$ 22.2 Bn in 2022 and is anticipated to grow at a CAGR of 18% from 2023-2033, according to a recently published Future Market Insights report. By the end of 2033, the market is expected to reach US$ 131.4 Bn. The increasing elderly populace, along with the rise in instances of cancer diagnoses, is …
NGS Sample Preparation Market is projected to advance at a CAGR of 13.7% from 2022 to 2032 | FMI Study
[342 Pages Report] The global NGS sample preparation market is expected to be valued at $5441.1 million by 2032, up from $1321.8 million in 2022, and to grow at a 13.7% CAGR during the forecast period (2022-2032). DNA contains the blueprints of life. Within its structures are the codes required for the assembly of proteins and non-coding …
Pancreatic Cancer Market is projected to accelerate at a CAGR of 13.5% to top US$ 7,541.09 Million by 2033
In 2023, the market for pancreatic cancer will be worth over US$2,125,57 million. By 2033, it is anticipated that the market for pancreatic cancer would grow at a CAGR of 13.5% and reach $7,541.09 million. The seventh greatest cause of cancer-related deaths worldwide, pancreatic cancer is one of the most often diagnosed cancers. In the West, pancreatic …
Age Related Molecular Degeneration Market is likely to propel to US$ 22.19 Million by 2033 | Exclusive Report by FMI
The global age-related molecular degeneration market is currently valued at US$ 11.28 Million in 2023 and is anticipated to expand at a CAGR of 7%. Owing to the technological advances in healthcare the market is likely to propel to US$ 22.19 Million by 2033. The increasing prevalence of AMD and a strong product pipeline are …